Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Assertio Therapeutics, IncSecurity delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Diadexus, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Diadexus, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Diadexus, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Diadexus, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Diadexus, Inc.Listing unverified | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Assertio Therapeutics, IncSecurity delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | Exercise | $346.6 | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Assertio Therapeutics, IncSecurity delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Assertio Therapeutics, IncSecurity delisted | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Assertio Therapeutics, IncSecurity delisted | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | Exercise | $53.3K | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | Exercise | $158.8K | Unusual size | SEC | |
GYRE THERAPEUTICS, INC.Listing on record | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Assertio Therapeutics, IncSecurity delisted | Exercise | $51.8K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | Exercise | $101.4K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | Exercise | $49.1K | SEC | ||
GYRE THERAPEUTICS, INC.Listing on record | Sell | $789.3K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Assertio Therapeutics, IncSecurity delisted | Exercise | $22.4K | SEC | ||
Assertio Therapeutics, IncSecurity delisted | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Assertio Therapeutics, IncSecurity delisted | Sell | $560.2K | SEC |